ERBB2 and breast carcinoma: Chattopadhyay et al. reported that HER2-targeted AuNPs increased the antitumor effect of radiotherapy in a xenograft model of breast cancer and that AuNPs are not harmful to normal tissue in vitro and in vivo [22,23].